A nurse is caring for a client who has bipolar disorder and a new prescription for valproate. Which of the following instructions should the nurse give the client about the use of this medication?

Choice A reason: This statement is incorrect because valproate toxicity is not directly related to serum sodium levels. Sodium levels are more relevant in the context of lithium therapy, where hyponatremia can increase lithium reabsorption and toxicity risk. Valproate metabolism and toxicity are primarily associated with hepatic function rather than sodium balance. Therefore, linking sodium levels to valproate toxicity is scientifically inaccurate. Choice B reason: This is the correct answer because valproate is extensively metabolized in the liver, and hepatotoxicity is a well-documented adverse effect. Monitoring liver function tests is essential to detect early signs of hepatic impairment, such as elevated transaminases, which can progress to severe liver injury if not addressed. The risk is particularly high in children under 2 years and in patients with preexisting liver disease. Routine monitoring ensures safe continuation of therapy and prevents life-threatening complications. Choice C reason: An electroencephalogram (EEG) is not required before initiating valproate therapy for bipolar disorder. EEGs are typically used in the evaluation of seizure disorders, not as a pretreatment requirement for mood stabilizers. While valproate is also an anticonvulsant, its use in bipolar disorder does not necessitate EEG monitoring. This choice is therefore irrelevant to the safe administration of valproate in psychiatric care. Choice D reason: Thyroid function monitoring is important for clients taking lithium, as lithium can impair thyroid function and lead to hypothyroidism. Valproate, however, does not have a significant effect on thyroid function. Thus, recommending thyroid function tests every 6 months is inappropriate in the context of valproate therapy. This choice confuses the monitoring requirements of lithium with those of valproate.